Building on our previous study characterizing NS4b as an OAS-RNase L antagonist (19), we have used recombinant MERS-CoV to furtherelucidate the roles of NS4a and NS4b during infection of human airway epithelium-derivedA549 cells (20). This evidence concerns the gene RNASEL and infection.